ÂÜÀòÂÒÂ×

As Chief Research Officer, Dr. Childers will lead the development of EncepHeal Therapeutics psychostimulant addiction therapeutics. With over 30+ years of experience he is widely regarded as a top expert in the field of biochemical neuropharmacology. Since 1999 his research has had a focus on the identification of potential medications to treat cocaine addiction. As part of that effort, his laboratory has screened over 600 novel compounds at brain target receptors to identify logical candidates for medication development.